• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Concordance of the Gleason score in prostate multibiopsy and definitive histology].

作者信息

May M, Brookman-May S, Lebentrau S, Gilfrich C, Loy V, Theissig F, Roigas J, Hoschke B, Burger M, Miller K

机构信息

Urologische Klinik, Klinikum St. Elisabeth Straubing, Straubing.

出版信息

Aktuelle Urol. 2010 May;41(3):184-92. doi: 10.1055/s-0030-1247306. Epub 2010 Mar 22.

DOI:10.1055/s-0030-1247306
PMID:20309804
Abstract

BACKGROUND

Due to an insufficient mean agreement between the Gleason score (GS) revealed from multibiopsy and definitive histology after radical prostatectomy (RP) of merely about 45 %, a modification of the GS including an elimination of GS 2-4 was -accomplished in 2005. The aim of the present study was to evaluate the concordance of GS and WHO grading in biopsy and definitive histology and to -determine parameters influencing the diagnostic accuracy of the biopsy and the prognosis.

MATERIALS AND METHODS

Within a 10-year-period before modification of the GS, radical prostatectomy was performed in 856 patients (study group, SG; mean age 64.2 years). The grade of agreement between GS and WHO grading in biopsy and definitive histology was calculated by kappa statistics (kappa) (for the complete and single time -periods). Furthermore, we assessed the univariable and multivariable influence of different preoperatively available parameters on disease-free survival (DFS). The mean follow-up period was 39 months (range: 10-139 months).

RESULTS

Undergrading of GS and WHO grading decreased continuously within the three time -periods in favour of a higher agreement regarding the histological results revealed from biopsy and definitive histology. However, we found only a poor to moderate agreement in the complete time period (kappa values of 0.354 for GS and 0.404 for WHO grading) that - with regard to both parameters - was improved by an increased number of biopsy cores taken. PSA value, clinical -tumour stage, number of positive cores (dichotomised at 34 %), annual RP case load (dichotomised at 75), and GS revealed an independent significant influence on DFS. Patients with GS 2-4 in the biopsy exhibited an upgrade to GS > or = 7 in only 5.7 %, and -showed, -independent of the definitive histology, a significantly better prognosis in comparison with patients presenting with a higher GS.

CONCLUSIONS

The results of the present study again suggest the independent prognostic impact of the GS revealed from biopsy. However, the concordance with the GS in the definitive histology remains deficient and is improvable by taking a higher number of biopsy cores. Although the elimination of GS 2-4 might be comprehensible for the pathologist's purpose, it results in a considerable loss of pretherapeutic prognostic information.

摘要

相似文献

1
[Concordance of the Gleason score in prostate multibiopsy and definitive histology].
Aktuelle Urol. 2010 May;41(3):184-92. doi: 10.1055/s-0030-1247306. Epub 2010 Mar 22.
2
External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.临床分期为T1-2期前列腺癌的体外放射治疗与根治性前列腺切除术:根据治疗前前列腺特异性抗原(PSA)水平和活检Gleason评分分层的治疗意义
Cancer J Sci Am. 1997 Mar-Apr;3(2):78-87.
3
Should we abstain from Gleason score 2-4 in the diagnosis of prostate cancer? Results of a German multicentre study.是否应避免在前列腺癌诊断中使用 Gleason 评分 2-4?德国多中心研究结果。
World J Urol. 2012 Feb;30(1):97-103. doi: 10.1007/s00345-010-0632-5. Epub 2010 Dec 30.
4
Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores.通过增加经直肠活检针芯数量提高预测前列腺癌Gleason评分的准确性。
Urol Int. 2007;79(4):302-6. doi: 10.1159/000109713.
5
Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.预测中、高级别前列腺癌患者显著分级变化的前列腺活检临床和病理变量。
BJU Int. 2009 Jan;103(1):43-8. doi: 10.1111/j.1464-410X.2008.08059.x. Epub 2008 Sep 8.
6
[Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].[前列腺癌分期:直肠内磁共振成像、活检 Gleason 评分及术前前列腺特异性抗原水平联合信息的价值]
Rofo. 2006 Apr;178(4):385-90. doi: 10.1055/s-2006-926475.
7
Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.前列腺癌分级:对前列腺穿刺活检 Gleason 评分 4+3 进行分层为高级别或中级别分组的影响。
BJU Int. 2010 Mar;105(5):631-5. doi: 10.1111/j.1464-410X.2009.08810.x. Epub 2009 Sep 3.
8
The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.前列腺穿刺活检癌灶在穿刺活检受累更严重一侧的百分比作为根治性前列腺切除术后前列腺特异性抗原复发的预测指标:来自共享平等准入区域癌症医院(SEARCH)数据库的结果
Cancer. 2003 Dec 1;98(11):2344-50. doi: 10.1002/cncr.11809.
9
Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.临床分期为T1c期前列腺癌患者病理分期的预测:新挑战
J Urol. 2002 Jul;168(1):100-4.
10
Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.扩展前列腺活检方案提高了 Gleason 分级的可靠性:对放疗患者的影响
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):386-91. doi: 10.1016/j.ijrobp.2003.10.014.

引用本文的文献

1
Gleason grading of prostate cancer in needle core biopsies: a comparison of general and urologic pathologists.针芯活检中前列腺癌的Gleason分级:普通病理学家与泌尿外科病理学家的比较
Ann Saudi Med. 2013 Jan-Feb;33(1):40-4. doi: 10.5144/0256-4947.2013.40.